Article
Thrombotic complications during cancer treatment in children.
Experimental oncology - 1 Sept 2007
Lipay N V, Dmitriev V V, Borisenok M B
Abstract excerpt
AIM: To determine the hereditary risk factors contributing to the development of thrombosis in children with cancer. METHODS: Sensitive PCR- restriction fragment length polymorphism assay. RESULTS: There has been shown significant prevalence of factor V leiden (FVL) in the group of 19 patients with thrombosis (P=0.0004). The prothrombin G20210A mutation was not detected in 19 cases and 80 controls, indicating low...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
